Literature DB >> 16149059

Regulation of human prostate-specific G-protein coupled receptor, PSGR, by two distinct promoters and growth factors.

Jinsheng Weng1, Wenbin Ma, Dianne Mitchell, Jianshe Zhang, Mingyao Liu.   

Abstract

PSGR is a newly identified human prostate tissue-specific gene belonging to the G-protein coupled receptor (GPCR) family. Overexpression of PSGR is associated with human prostate intraepithelial neoplasia (PIN) and prostate tumors, suggesting PSGR may play an important role in early prostate cancer development and progression. To understand the regulation of tissue-specific expression of human PSGR and its upregulation mechanism in prostate cancers, we characterized the promoter region of PSGR and analyzed the control mechanism for PSGR expression in human prostate tissues/cells. In this report, we demonstrate that two distinct promoters control the transcriptional regulation of PSGR in human prostate cells. The first promoter region includes exon 1 and a TATA box at -31 site. The minimal DNA sequence with promoter activity is about 123 bp upstream of exon 1. Exon 1 contains tissue specific regulatory activity for the first promoter of PSGR gene. The second promoter is located in the upstream region of exon 2, which is a TATA-less and non-GC-rich promoter. Primer extension and RNA protection assays (RPA) revealed that the transcription driven by the second promoter is initiated at the junction of intron and exon 2 within a cluster of nucleotides located about 250 bp upstream from the junction. Both promoters show prostate cell-specific characteristics in our luciferase assays in transfected cells. Furthermore, we investigated the regulation of the promoter activities of the PSGR gene by different growth factors and cytokines, and demonstrated that interleukin-6 (IL-6) activates the promoter activities of PSGR in human prostate cancer cells. These data suggest that two functional promoters regulate the transcriptional expression of PSGR in human prostate tissues and PSGR is a new target for IL-6 transcriptional regulation. 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16149059     DOI: 10.1002/jcb.20600

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  10 in total

1.  Novel 5' fusion partners of ETV1 and ETV4 in prostate cancer.

Authors:  João D Barros-Silva; Paula Paulo; Anne Cathrine Bakken; Nuno Cerveira; Marthe Løvf; Rui Henrique; Carmen Jerónimo; Ragnhild A Lothe; Rolf Inge Skotheim; Manuel R Teixeira
Journal:  Neoplasia       Date:  2013-07       Impact factor: 5.715

2.  Prostate-specific G-protein-coupled receptor collaborates with loss of PTEN to promote prostate cancer progression.

Authors:  M Rodriguez; S Siwko; L Zeng; J Li; Z Yi; M Liu
Journal:  Oncogene       Date:  2015-06-01       Impact factor: 9.867

3.  Functional characterization of the GDEP promoter and three enhancer elements in retinoblastoma and prostate cell lines.

Authors:  D S Cross; J K Burmester
Journal:  Med Oncol       Date:  2007-06-27       Impact factor: 3.064

4.  Identification of special AT-rich sequence binding protein 1 as a novel tumor antigen recognized by CD8+ T cells: implication for cancer immunotherapy.

Authors:  Mingjun Wang; Bingnan Yin; Satoko Matsueda; Lijuan Deng; Ying Li; Wei Zhao; Jia Zou; Qingtian Li; Christopher Loo; Rong-Fu Wang; Helen Y Wang
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

5.  Identification of prostate-specific G-protein coupled receptor as a tumor antigen recognized by CD8(+) T cells for cancer immunotherapy.

Authors:  Satoko Matsueda; Mingjun Wang; Jinsheng Weng; Ying Li; Bingnan Yin; Jia Zou; Qingtian Li; Wei Zhao; Weiyi Peng; Xavier Legras; Christopher Loo; Rong-Fu Wang; Helen Y Wang
Journal:  PLoS One       Date:  2012-09-20       Impact factor: 3.240

6.  PSGR promotes prostatic intraepithelial neoplasia and prostate cancer xenograft growth through NF-κB.

Authors:  M Rodriguez; W Luo; J Weng; L Zeng; Z Yi; S Siwko; M Liu
Journal:  Oncogenesis       Date:  2014-08-11       Impact factor: 7.485

7.  Oncodomains: A protein domain-centric framework for analyzing rare variants in tumor samples.

Authors:  Thomas A Peterson; Iris Ivy M Gauran; Junyong Park; DoHwan Park; Maricel G Kann
Journal:  PLoS Comput Biol       Date:  2017-04-20       Impact factor: 4.475

8.  Ectopically expressed olfactory receptors OR51E1 and OR51E2 suppress proliferation and promote cell death in a prostate cancer cell line.

Authors:  Alexey Pronin; Vladlen Slepak
Journal:  J Biol Chem       Date:  2021-02-25       Impact factor: 5.157

Review 9.  Odorant receptors in cancer.

Authors:  Chan Chung; Hee Jin Cho; ChaeEun Lee; JaeHyung Koo
Journal:  BMB Rep       Date:  2022-02       Impact factor: 4.778

10.  Translation levels control multi-spanning membrane protein expression.

Authors:  Hok Seon Kim; James A Ernst; Cecilia Brown; Jenny Bostrom; Germaine Fuh; Chingwei V Lee; Arthur Huang; Richard L Vandlen; Daniel G Yansura
Journal:  PLoS One       Date:  2012-04-26       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.